Diagnostics and antimicrobial therapy

  30 September 2022

The use of rapid diagnostic tests to aid appropriate antimicrobial therapy can have a huge impact on patient outcomes and clinical awareness. Most importantly, access to diagnostic tools is not equal across the board with low-and-middle-income countries often lacking the necessary infrastructure to support, for example, timely antimicrobial susceptibility testing of bacteria. Furthermore, while there is a significant drive to fill the antibiotic abyss, improving equitable access to current and new diagnostic tools is equally important, and requires a multisectoral approach.

To discuss the integral role of diagnostics in the context of antimicrobial resistance, as well as some of the latest initiatives helping to drive progress in this area, Lorna Rothery spoke to the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR) SAB Chair and expert on diagnostics, Professor Till Bachmann.

Further reading: Health Europe
Author(s): Lorna Rothery
Healthy Animals   Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Evotec

JSS University

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!